Author + information
- Received May 6, 2004
- Accepted August 25, 2004
- Published online December 7, 2004.
- Abdou Elhendy, MD, PhD, FACC*,
- Edward L. O'Leary, MD, FACC*,
- Feng Xie, MD*,
- Anna C. McGrain, BSN, RN*,
- James R. Anderson, PhD† and
- Thomas R. Porter, MD, FACC*,* ()
- ↵*Reprint requests and correspondence:
Dr. Thomas R. Porter, 981165 Nebraska Medical Center, Omaha, Nebraska 68198-1165
Objective This study sought to compare the accuracy of myocardial contrast echocardiography (MCE) and wall motion analysis (WMA) during submaximal and peak dobutamine stress echocardiography (DSE) for the diagnosis of coronary artery disease (CAD).
Background The relative merits of MCE and WMA for the detection of CAD during DSE have not been studied in a large number of patients.
Methods We studied 170 patients who underwent dobutamine (up to 50 μg/kg/min)-atropine stress testing and coronary angiography. The WMA and MCE (using repeated boluses of Optison [Mallinckrodt, St. Louis, Missouri] or Definity [Bristol-Myers Squibb, New York, New York]) were performed at rest, at intermediate stress (65% to 75% of maximal heart rate), and at peak stress. The diagnosis of CAD (≥50% stenosis in ≥1 coronary artery) was based on reversible wall motion and perfusion abnormalities.
Results Coronary artery disease was detected in 127 (75%) patients. Sensitivity of MCE was higher than that of WMA at maximal stress (91% vs. 70%; p = 0.001) and at intermediate stress (84% vs. 20%; p = 0.0001). Specificity was lower for MCE compared with WMA (51% vs. 74%; p = 0.01). Overall accuracy was higher for MCE than for WMA (81% vs. 71%; p = 0.01). Sensitivity for detection of CAD based on abnormalities in ≥2 vascular regions was higher for MCE than for WMA (67% vs. 28%; p < 0.01).
Conclusions The majority of inducible perfusion abnormalities occur at an intermediate phase of the stress test, without wall motion abnormalities. Myocardial contrast echocardiography provides better sensitivity than WMA, particularly in patients with submaximal stress and in identifying patients with multivessel CAD.
- Received May 6, 2004.
- Accepted August 25, 2004.
- American College of Cardiology Foundation